# Study on the Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-2004 Injection in Adult Patients With Atrial Fibrillation

> **NCT06280768** · PHASE1 · UNKNOWN · sponsor: **Beijing Suncadia Pharmaceuticals Co., Ltd** · enrollment: 48 (estimated)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** SHR-2004 injection

## Key facts

- **NCT ID:** NCT06280768
- **Lead sponsor:** Beijing Suncadia Pharmaceuticals Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2024-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06280768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06280768, "Study on the Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-2004 Injection in Adult Patients With Atrial Fibrillation". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06280768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*